Literature DB >> 10518280

Adolescent myopathic presentation in two sisters with very long-chain acyl-CoA dehydrogenase deficiency.

B Merinero1, S I Pascual Pascual, C Pérez-Cerdá, J Gangoiti, M Castro, M J Garcia, I Pascual Castroviejo, C Vianey-Saban, B Andresen, N Gregersen, M Ugarte.   

Abstract

Two sisters were investigated at the ages of 20 and 13 years owing to persistently increased serum creatine kinase and recurrent episodes of rhabdomyolysis after emotional stress in the older and myalgias in the younger. The finding of increased levels of cis-5-tetradecenoic acid (C14:1) in plasma, severe hypocarnitinaemia and the absence of a pathological dicarboxylic aciduria in both sisters suggested a very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. Reduced [1-(14)C]palmitate oxidation and deficient mitochondrial VLCAD activity in fibroblasts were found. Mutation analysis revealed compound heterozygosity for Asp365His and Arg410His changes. This late-onset, milder clinical presentation differs from the other two more severe infantile phenotypes described, since there is no hypoglycaemia or cardiac disease. Fatty acid oxidation defects should be investigated in all cases with rhabdomyolysis beginning in adolescence or early adulthood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518280     DOI: 10.1023/a:1005553907216

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  18 in total

1.  A rapid procedure for extracting genomic DNA from leukocytes.

Authors:  S W John; G Weitzner; R Rozen; C R Scriver
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

2.  Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography.

Authors:  C G Costa; E A Struys; A Bootsma; H J ten Brink; L Dorland; I Tavares de Almeida; M Duran; C Jakobs
Journal:  J Lipid Res       Date:  1997-01       Impact factor: 5.922

3.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

4.  Very-long-chain acyl-coenzyme A dehydrogenase deficiency in a child with recurrent myoglobinuria.

Authors:  C Minetti; B Garavaglia; M Bado; F Invernizzi; C Bruno; M Rimoldi; R Pons; F Taroni; G Cordone
Journal:  Neuromuscul Disord       Date:  1998-02       Impact factor: 4.296

5.  Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.

Authors:  J Schaefer; S Jackson; D J Dick; D M Turnbull
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

6.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.

Authors:  C Vianey-Saban; P Divry; M Brivet; M Nada; M T Zabot; M Mathieu; C Roe
Journal:  Clin Chim Acta       Date:  1998-01-12       Impact factor: 3.786

Review 7.  Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations.

Authors:  S I Goodman; D E Stein; S Schlesinger; E Christensen; M Schwartz; C R Greenberg; O N Elpeleg
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 8.  Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia.

Authors:  C Vianey-Saban; B Mousson; C Bertrand; D Stamm; R Dumoulin; M T Zabot; P Divry; D Floret; M Mathieu
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

9.  Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria.

Authors:  I Ogilvie; M Pourfarzam; S Jackson; C Stockdale; K Bartlett; D M Turnbull
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

Review 10.  Metabolic myopathies.

Authors:  I Tein
Journal:  Semin Pediatr Neurol       Date:  1996-06       Impact factor: 1.636

View more
  7 in total

1.  Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).

Authors:  F Fatehi; A A Okhovat; Y Nilipour; M Mroczek; V Straub; A Töpf; A Palibrk; S Peric; V Rakocevic Stojanovic; H Najmabadi; S Nafissi
Journal:  Eur J Neurol       Date:  2020-07-24       Impact factor: 6.089

2.  Four Years' Experience in the Diagnosis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanish Newborn Screening Centers.

Authors:  B Merinero; P Alcaide; E Martín-Hernández; A Morais; M T García-Silva; P Quijada-Fraile; C Pedrón-Giner; E Dulin; R Yahyaoui; J M Egea; A Belanger-Quintana; J Blasco-Alonso; M L Fernandez Ruano; B Besga; I Ferrer-López; F Leal; M Ugarte; P Ruiz-Sala; B Pérez; C Pérez-Cerdá
Journal:  JIMD Rep       Date:  2017-07-29

3.  Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil.

Authors:  J I Ruiz-Sanz; L Aldamiz-Echevarria; J Arrizabalaga; L Aquino; P Jimeno; G Pérez-Nanclares; P Sanjurjo
Journal:  J Inherit Metab Dis       Date:  2001-08       Impact factor: 4.982

4.  Emotionally-intense situations can result in rhabdomyolysis in McArdle disease.

Authors:  Stefen Brady; Richard Godfrey; Renata S Scalco; Ros M Quinlivan
Journal:  BMJ Case Rep       Date:  2014-10-07

Review 5.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26

6.  Adult-onset Repeat Rhabdomyolysis with a Very Long-chain Acyl-CoA Dehydrogenase Deficiency Due to Compound Heterozygous ACADVL Mutations.

Authors:  Yasuhiro Fuseya; Takeyo Sakurai; Jun-Ichi Miyahara; Kei Sato; Seiji Kaji; Yoshihiko Saito; Makio Takahashi; Ichizo Nishino; Tokiko Fukuda; Hideo Sugie; Hirofumi Yamashita
Journal:  Intern Med       Date:  2020-07-14       Impact factor: 1.271

7.  Rhabdomyolysis in a neonate due to very long chain acyl CoA dehydrogenase deficiency.

Authors:  Jessica Scott Schwoerer; Gena Cooper; Sandra van Calcar
Journal:  Mol Genet Metab Rep       Date:  2015-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.